These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8737176)

  • 1. The effect of concomitant use of neuroleptic drugs and lithium on the erythrocyte/plasma lithium ratio in Iranian patients with bipolar disorder.
    Azizabadi-Farahani M; Mirazi N; Azar M; Farsam H; Dehpour AR
    J Clin Pharm Ther; 1996 Feb; 21(1):3-7. PubMed ID: 8737176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte lithium transport during lithium treatment in patients with affective disorders.
    Zaremba D; Rybakowski J
    Pharmacopsychiatry; 1986 Mar; 19(2):63-7. PubMed ID: 3085111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocyte/plasma ratio of lithium. Determination method and individual stability].
    Barthelmebs M; Ehrhardt JD; Schweitzer-Ehret A; Danion JM; Imbs JL
    Encephale; 1993; 19(4):321-7. PubMed ID: 8275919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in erythrocyte:plasma lithium ratio by concurrent administration of psychotropic drugs and lithium in mice.
    Sadeghipour-Roudsari HR; Farahani M; Shokrgozar AA; Farsam H; Dehpour AR
    Gen Pharmacol; 1998 Jul; 31(1):63-6. PubMed ID: 9595281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative prophylactic efficacy of lithium and carbamazepine in patients with bipolar I disorder.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):277-81. PubMed ID: 10529070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
    Greil W; Kleindienst N
    Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol deficiency diet and lithium effects.
    Shaldubina A; Stahl Z; Furszpan M; Regenold WT; Shapiro J; Belmaker RH; Bersudsky Y
    Bipolar Disord; 2006 Apr; 8(2):152-9. PubMed ID: 16542185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and neuroleptic drugs in combination - effect on lithium RBC/plasma ratio.
    von Knorring L; Smigan L; Perris C; Oreland L
    Int Pharmacopsychiatry; 1982; 17(4):287-92. PubMed ID: 6136488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium-neuroleptic neurotoxicity in the elderly bipolar patient.
    Miller F; Menninger J; Whitcup SM
    J Clin Psychopharmacol; 1986 Jun; 6(3):176-8. PubMed ID: 2872237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous lithium and boron red cell-plasma ratios: normal subjects versus bipolar patients not on lithium therapy.
    Clarke WB; Guscott R; Downing RG; Lindstrom RM
    Biol Trace Elem Res; 2004 Feb; 97(2):105-16. PubMed ID: 14985621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of the lithium erythrocyte: plasma ratio to plasma lithium level.
    Schreiner HC; Dunner DL; Meltzer HL; Fieve RR
    Biol Psychiatry; 1979 Feb; 14(1):207-13. PubMed ID: 420901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors contributing to erythrocyte lithium-sodium countertransport activity in lithium-treated bipolar patients.
    Rybakowski JK; Amsterdam JD; Dyson WL; Frazer A; Winokur A; Kurtz J
    Pharmacopsychiatry; 1989 Jan; 22(1):16-20. PubMed ID: 2710807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients.
    Rosa AR; Marco M; Fachel JM; Kapczinski F; Stein AT; Barros HM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):217-24. PubMed ID: 16982121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lithium and carbamazepine combination in the treatment of bipolar disorder--a preliminary report.
    Inoue K; Arima S; Tanaka K; Fukui Y; Kato N
    Folia Psychiatr Neurol Jpn; 1981; 35(4):465-75. PubMed ID: 6806160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lithium and neuroleptic combination on lithium transport, blood pressure, and weight in bipolar patients.
    Ghadirian AM; Nair NP; Schwartz G
    Biol Psychiatry; 1989 Jun; 26(2):139-44. PubMed ID: 2736263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.